Most Read News

The company's claimed reasons for the split include increased share liquidity, affordability, and a broader investor base.

Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.

Earlier this week, Bahadur Dastoor resigned as the company's Chief Financial Officer (CFO), effective September 21.

The estimated total investment for these projects is around ₹48,000 Crore, which is anticipated to create nearly 8,400 direct and indirect jobs.

On the NSE, market breadth shows 1,322 stocks advancing while 1,146 stocks are declining.

However, it is unclear whether the Hyderabad-based company will be Cobenfy's exclusive supplier.

Recently, RITES announced a bonus share allotment of 1:1 and a final dividend of ₹5 per share for eligible shareholders.

The company said that ₹592.26 Crore will be paid in cash, while ₹239.25 Crore will be paid through a share transfer, resulting in a 3.17% holding in Nazara.

The sale was formalized through a deed of conveyance on September 26, 2024, encompassing both the land and building associated with the property.

The order is for the procurement of materials and installation of a solar power producing plant of 130 MWp/100 MWac.